Issued Patents All Time
Showing 1–25 of 28 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 9765340 | RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of CAMP-related ocular disorders | John M. Yanni, Jon E. Chatterton, Daniel A. Gamache | 2017-09-19 |
| 9745585 | RNAi-mediated inhibition of histamine receptor H1-related conditions | John M. Yanni, Jon E. Chatterton, Daniel A. Gamache | 2017-08-29 |
| 9453220 | RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of cAMP-related ocular disorders | John M. Yanni, John E. Chatterton, Daniel A. Gamache | 2016-09-27 |
| 9447419 | RNAi-mediated inhibition of tumor necrosis factor α-related conditions | John M. Yanni, Jon E. Chatterton, Diane Michelle Senchyna, Daniel A. Gamache | 2016-09-20 |
| 9371529 | RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions | John M. Yanni, Jon E. Chatterton, Daniel A. Gamache | 2016-06-21 |
| 9206428 | RNAi-mediated inhibition of histamine receptor H1-related conditions | John M. Yanni, Jon E. Chatterton, Daniel A. Gamache | 2015-12-08 |
| 8865671 | RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions | John M. Yanni, Jon E. Chatterton, Daniel A. Gamache | 2014-10-21 |
| 8673873 | RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of cAMP-related ocular disorders | John M. Yanni, Jon E. Chatterton, Daniel A. Gamache | 2014-03-18 |
| 8618278 | RNAi-mediated inhibition of histamine receptor H1-related conditions | John M. Yanni, Jon E. Chatterton, Daniel A. Gamache | 2013-12-31 |
| 8541389 | RNAi-mediated inhibition of tumor necrosis factor α-related conditions | John M. Yanni, Jon E. Chatterton, Diane Michelle Senchyna, Daniel A. Gamache | 2013-09-24 |
| 8222227 | RNAi-mediated inhibition of histamine receptor H1-related conditions | John M. Yanni, Jon E. Chatterton, Daniel A. Gamache | 2012-07-17 |
| 8048863 | RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions | John M. Yanni, Jon E. Chatterton, Daniel A. Gamache | 2011-11-01 |
| 8017592 | RNAi-mediated inhibition of histamine receptor H1-related conditions | John M. Yanni, Jon E. Chatterton, Daniel A. Gamache | 2011-09-13 |
| 7906512 | 3,6-substituted imidazol[1,2-b]pyridazine analogs for treating allergic and inflammatory diseases | Mark R. Hellberg, Andrew Rusinko | 2011-03-15 |
| 7799778 | 5-substituted 2-aminopyridine analogs for treating allergic and inflammatory diseases | Mark R. Hellberg, Andrew Rusinko | 2010-09-21 |
| 7732421 | RNAI-mediated inhibition of tumor necrosis factor α-related conditions | John M. Yanni, Jon E. Chatterton, Diane Michelle Senchyna, Daniel A. Gamache | 2010-06-08 |
| 7713975 | 3,6-substituted imidazol[1,2-b]pyridazine analogs for treating allergic and inflammatory diseases | Mark R. Hellberg, Andrew Rusinko | 2010-05-11 |
| 6506802 | Disulfide derivatives useful for treating allergic diseases | Zixia Feng, Mark R. Hellberg | 2003-01-14 |
| 6500864 | Disulfide derivatives useful for treating allergic diseases | Zixia Feng, Mark R. Hellberg | 2002-12-31 |
| 6492418 | Compositions containing a benzamide disulfide derivative for treating allergic diseases | Mark R. Hellberg, Zixia Feng | 2002-12-10 |
| 6492552 | Disulfide derivatives useful for treating allergic diseases | Zixia Feng, Mark R. Hellberg | 2002-12-10 |
| 6452052 | Aniline disulfide derivatives for treating allergic diseases | Mark R. Hellberg, Zixia Feng | 2002-09-17 |
| 6372802 | Aniline disulfide derivatives for treating allergic diseases | Mark R. Hellberg, Zixia Feng | 2002-04-16 |
| 6274160 | Methods of use of histamine H2 agonists in treating dry eye | Daniel A. Gamache, John M. Yanni | 2001-08-14 |
| 6225327 | Compounds which inhibit human conjunctival mast cell degranulation for treating ocular allergic-type complications | Mark R. Hellberg, John M. Yanni | 2001-05-01 |